NOBESITA
Obesity among pets is becoming a problem. More than 50% of all kjærledyr In the United States are obese. Obesity leads to heart disease, diabetes, move, play, etc. and increases the risk of an early death. Nobesita develops new supplements with weight-reducing effect aimed at pets. The dietary supplement developed by researchers at the University of Bergen.
NOBESITA
Industry:
Biotechnology Fitness Health Care
Address:
Oslo, Oslo, Norway
Country:
Norway
Status:
Active
Total Funding:
0
Investors List
BTO
BTO investment in Funding Round - Nobesita